Ciphero | $2,500,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
Givefront | $2,000,000 | (Dec 23, 2025)
Avenda Health
United States
- Culver City, California
- 30/08/2022
- Series B
- $10,000,000
1 in 7 men will be diagnosed with prostate cancer in their lifetime, and the current standard of care in treatment significantly impairs quality of life due to imprecision.
Avenda Health is creating a more personalized future of prostate cancer care. We've built a platform that uses deep learning to map a patient's cancer in 3D, giving physicians precise information and the confidence to make care decisions. This is paired with a proprietary targeted ablative therapy that can treat patients in a doctors office under local anesthesia. Avenda Health aims to improve outcomes, preserve quality of life, and create a new standard of cancer care.
- Industry Medical Equipment Manufacturing
- Website https://avendahealth.com/
- LinkedIn https://www.linkedin.com/company/avenda-health/
Related People
Shyam NatarajanCo Founder
United States -
Los Angeles, California
Focused on improving clinical outcomes and patient care in urology and beyond.
Leading a clinical-stage AI healthcare startup that is creating a more personalized future of prostate cancer care. Previously led an NIH-funded lab focusing on image-guided cancer interventions at UCLA with a background in software engineering.
StretchSense | $2,300,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
Peripheral Labs | $3,600,000 | (Dec 23, 2025)
Ethereal Exploration Guild | $21,000,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)